Articles by Cynthia Challener, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Cynthia Challener, PhD

Advances in Continuous Biopharmaceutical Manufacturing

Both upstream and downstream processes can benefit from continuous manufacturing advantages.
Apr 16, 2014

Both upstream and downstream processes can benefit from continuous manufacturing advantages.

Appropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.
Apr 2, 2014

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.

Increased Efficiency Key to Competitiveness in Downstream Bioprocessing

Higher antibody titers and a growing demand for smaller-volume, flexible processes are creating the need for more cost-effective downstream processing.
Apr 2, 2014

Higher antibody titers and a growing demand for smaller-volume, flexible processes are creating the need for more cost-effective downstream processing.

Drug Delivery Technologies Provide Growth Opportunities for Biopharmaceuticals

Advanced drug delivery technologies can increase efficacy and safety, extend patent lives, and provide competitive differentiation for biopharmaceuticals.
Apr 1, 2014

Advanced drug delivery technologies can increase efficacy and safety, extend patent lives, and provide competitive differentiation for biopharmaceuticals.

Synthetic Biology Stirs Interest in Greener, More Efficient Processes

The commercial availability of an increasing diversity of enzymes has led to the growing use of biocatalysts for API synthesis.
Apr 1, 2014

The commercial availability of an increasing diversity of enzymes has led to the growing use of biocatalysts for API synthesis.

Synthetic Biology: The Next Frontier in Chiral Chemistry for API Synthesis

The commercial availability of an increasing diversity of enzymes has led to the growing use of biocatalysts for API synthesis.
Mar 2, 2014

The commercial availability of an increasing diversity of enzymes has led to the growing use of biocatalysts for API synthesis.

Regulatory Initiatives Spur API Supply Chain Security

Several recent regulatory initiatives designed to secure the global pharmaceutical supply chain have been implemented or are in the process of being adopted.
Feb 28, 2014

In order to ensure a safe drug supply chain, governments have implemented both legislated and voluntary programs designed to address problem areas.

Demand Increases for Novel Excipients, but Manufacturers Still Face Challenges

Feb 28, 2014

Drug formulators are looking for new excipients to address solubility and bioavailability issues and extend patent protection, but there are hurdles to using novel, specialized ingredients.

Securing the Global API Supply Chain

Several recent regulatory initiatives designed to secure the global pharmaceutical supply chain have been implemented or are in the process of being adopted.
Feb 2, 2014

Recent regulatory initiatives designed to secure the global pharmaceutical supply chain will directly impact the global supply chain and API manufacturers.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here